Olr490 inhibitors represent a class of chemical compounds that interact specifically with the olfactory receptor 490 (Olr490), a G protein-coupled receptor (GPCR) predominantly involved in olfactory signaling pathways. These inhibitors are characterized by their ability to modulate the receptor's activity, often by binding to specific sites on the receptor and altering its conformation. The molecular structure of Olr490 inhibitors is typically designed to fit the binding pocket of the Olr490 receptor with high specificity, ensuring effective interaction at the molecular level. This interaction can lead to the inhibition of the receptor's natural function, which in the context of olfactory receptors, involves the recognition and transduction of specific odorant molecules. The inhibition process often results from either competitive or allosteric modulation, where the inhibitor either directly competes with the natural ligand for the binding site or induces a conformational change in the receptor, reducing its ability to interact with the ligand.
The study and design of Olr490 inhibitors involve understanding the receptor's structure, including its active sites, and the dynamics of receptor-ligand interactions. Researchers utilize various computational and experimental approaches, such as molecular docking and structure-activity relationship (SAR) studies, to identify and optimize compounds that effectively inhibit Olr490. These inhibitors are also important tools in studying the fundamental biology of olfactory receptors and their roles in chemosensory systems. By blocking the function of Olr490, scientists can dissect the receptor's contributions to olfactory signaling and explore the broader implications of receptor inhibition on related biochemical pathways. The development and characterization of these inhibitors provide insights into receptor-ligand interactions at a molecular level, contributing to the broader field of receptor biology and chemical signaling.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK, which can influence metabolic pathways and potentially proteins associated with them. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor, affecting the MAPK/ERK pathway and potentially proteins involved in this signaling cascade. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, altering the AKT signaling pathway, which may affect proteins downstream of this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which can influence proteins involved in cell growth and proliferation pathways. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits the TGF-β pathway, potentially affecting proteins involved in this signaling process. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits CaMKII, potentially affecting proteins associated with calcium signaling. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Modulates ion channels, potentially influencing proteins involved in neuronal signaling pathways. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Inhibits Wnt processing and secretion, potentially affecting proteins in the Wnt signaling pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, potentially affecting proteins involved in cytoskeleton organization and cell motility. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, potentially influencing proteins in the MAPK/ERK pathway. | ||||||